About me
I am an independent analyst looking at the intersection of strategy, capital, and industry structure. I focus on how biopharma industry creates value, and how investors generate returns.
My perspective is informed by a career spent as both a strategy consultant and an in-house corporate strategist.
I share my perspective through essays, macro presentations, and a weekly newsletter that highlights only the most important shifts in the industry.
